Content about Salicylates

April 21, 2013

UrgentRx's fast powder OTC treatments are beginning to show up at the check-stand. As a brand offering, it represents a unique delivery format with unique merchandising opportunities. DSN sought out founder and president Jordan Eisenberg for the details.

UrgentRx's fast powder OTC treatments are beginning to show up at the check-stand. As a brand offering, it represents a unique delivery format with unique merchandising opportunities. DSN sought out founder and president Jordan Eisenberg for the details.

DSN: What is the point of differentiation for the line?

January 29, 2013

"Talk to your cardiologist." That's the advice offered last week by Wills Eye Institute, a hospital specializing in eye care, following a JAMA article linking aspirin therapy to macular degeneration.

PHILADELPHIA — "Talk to your cardiologist." That's the advice offered Friday by Wills Eye Institute, a hospital specializing in eye care,  following a JAMA article linking aspirin therapy to macular degeneration. 

December 5, 2012

Patients once considered "aspirin resistant" may not be resistant to aspirin after all, according to a study published online by Circulation, the journal of the American Heart Association. Rather, the protective coating around the aspirin to prevent stomach issues may be delaying the absorption of aspirin, leading clinicians to believe that patients are aspirin resistant.

PHILADELPHIA — Patients once considered "aspirin resistant" may not be resistant to aspirin after all, according to a study published online by Circulation, the journal of the American Heart Association. Rather, the protective coating around the aspirin to prevent stomach issues may be delaying the absorption of aspirin, leading clinicians to believe that patients are aspirin resistant. 

November 8, 2012

Recent research from the Rothman Institute at Jefferson has shown aspirin to be just as effective in preventing clots — specifically pulmonary emboli, life-threatening blood clots that can develop in the arteries of the lungs following joint replacement surgery — Thomas Jefferson University announced Wednesday.

PHILADELPHIA – Recent research from the Rothman Institute at Jefferson has shown aspirin to be just as effective in preventing clots — specifically pulmonary emboli, life-threatening blood clots that can develop in the arteries of the lungs following joint replacement surgery — Thomas Jefferson University announced Wednesday. 

October 25, 2012

Aspirin has the potential to block tumor growth in certain patients with colorectal cancer, according to an editorial in the Oct. 25, 2012 issue of the New England Journal of Medicine by a University of Alabama at Birmingham oncologist.

 BIRMINGHAM, Ala. — Aspirin has the potential to block tumor growth in certain patients with colorectal cancer, according to an editorial in the Oct. 25, 2012 issue of the New England Journal of Medicine by a University of Alabama at Birmingham oncologist. In a study that appears in the same issue, researchers examined the use of aspirin in the treatment outcomes of patients with colorectal cancer.

September 14, 2012

The Food and Drug Administration on Thursday alerted the public that certain external analgesics have been associated with burns.

 SILVER SPRING, Md. — The Food and Drug Administration on Thursday alerted the public that certain external analgesics have been associated with burns. Most of the reported cases involved products containing higher concentrations of menthol and methyl salicylate (greater than 3% menthol or 10% methyl salicylate). Few of the cases involved capsaicin, the FDA reported. 

August 30, 2012

Men who have been treated for prostate cancer, either with surgery or radiation, could benefit from taking aspirin regularly, according to a multicenter study published in Tuesday's issue of the Journal of Clinical Oncology.

DALLAS — Men who have been treated for prostate cancer, either with surgery or radiation, could benefit from taking aspirin regularly, according to a multicenter study published in Tuesday's issue of the Journal of Clinical Oncology.